IgA-nefropátia: vizsgálatok itt: Egyesült Államok

In Egyesült Államok 26 Also abroad 92

26 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
Where
Cincinnati, Memphis, Neptune City, Oklahoma City
Életkor
2 év to 18 év
People
28 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07498335
3. fázisTaking people
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Where
Albuquerque, Arlington, Birmingham, Boise, Chicago, Cincinnati, City of Saint Peters, Columbus, Dallas, East Point, East Providence, Edina, El Paso, Fremont, Houston, Jacksonville, Kansas City, Katy, Lansing, Lauderdale Lakes, Los Angeles, Media, Melbourne, Miami, Montgomery, Morgantown, Orange, Orlando, Pembroke Pines, Philadelphia, Pontiac, Riverview, Rockford, Saint Joseph, Salt Lake City, San Antonio, Sanford, San Francisco, Shreveport, Surprise, Winston-Salem
Életkor
18 év and over
People
347 worldwide
Run by
Takeda
See details and how to joinNCT06963827 · EU 2025-520825-19-00
3. fázisTaking people
A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Where
Arvada, Atlanta, Katy, Lauderdale Lakes
Életkor
18 év and over
People
480
Run by
Jade Biosciences, Inc.
See details and how to joinNCT07902817 · EU 2026-527177-11-00
2. fázisTaking people
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Where
Arvada, Chula Vista, Denver, Houston, Orlando, Pembroke Pines
Életkor
18 év to 60 év
People
30 worldwide
Run by
Jade Biosciences, Inc.
See details and how to joinNCT07541287
2. fázisTaking people
A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN
Where
Houston, Manassas, Miami, Pembroke Pines, Pontiac, Salt Lake City, Valencia
Életkor
18 év and over
People
120 worldwide
Run by
argenx
See details and how to joinNCT07773727 · EU 2026-525638-43-00
2. fázisTaking people
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Where
Acworth, Denver, Edina, Iowa City, San Francisco
Életkor
18 év and over
People
32 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07146906 · EU 2024-519699-24-00
2. fázisTaking people
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Where
Columbus, Dakota Dunes, Dallas, Doral, Great Neck, Houston, Iowa City, Miami, Pembroke Pines, Shelby, Shreveport
Életkor
18 év and over
People
45 worldwide
Run by
ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06989359
3. fázisCsak meghívásos
A Phase 3 Open-Label Study of Long-term Treatment With Povetacicept in Adults With Immunoglobulin A Nephropathy
Where
Arvada, Houston, Idaho Falls, Orlando
Életkor
18 év and over
People
605
Run by
Vertex Pharmaceuticals Incorporated
See details and how to joinNCT07807995 · EU 2025-525064-14-00
3. fázisTaking people
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Where
Acworth, Apple Valley, Boston, Bradenton, Brookhaven, Carlsbad, City of Saint Peters, Dallas, Detroit, Gainesville, Garden Grove, Hollywood, Houston, Katy, Knoxville, Little Rock, Los Angeles, Milwaukee, New York, Orlando, Oxnard, Philadelphia, Pontiac, Port Saint Lucie, Providence, San Dimas, The Bronx, Worcester
Életkor
18 év and over
People
454 worldwide
Run by
Biogen
See details and how to joinNCT06935357 · EU 2024-519345-30-00
2. fázisTaking people
Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
Where
Jacksonville, Rochester
Életkor
18 év and over
People
16
Run by
Mayo Clinic
See details and how to joinNCT06676579
3. fázisTaking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Aurora, Baltimore, Boston, Chubbuck, Dallas, Glendale, Hinsdale, Houston, Jersey City, Kansas City, Las Vegas, Newark, New York, Rochester, San Diego, San Dimas
Életkor
18 év to 100 év
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
2. fázisTaking people
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
Where
Hollywood, Lawrenceville, Orangeburg
Életkor
16 év and over
People
30 worldwide
Run by
Akebia Therapeutics
See details and how to joinNCT06419205
4. fázisNot yet taking people in Egyesült Államok
Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)
Where
Chicago
Életkor
18 év and over
People
20
Run by
University of Illinois Chicago
See details and how to joinNCT07820995
3. fázisTaking people
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Where
Aurora, Gainesville, Madera, Philadelphia, Salt Lake City
Életkor
2 év to 18 év
People
31 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06994845
1/2. fázisTaking people
PS-002 for the Treatment of IgA Nephropathy in Adults
Where
Baltimore, Miami
Életkor
18 év and over
People
32 worldwide
Run by
Purespring Therapeutics Limited
See details and how to joinNCT07182227 · EU 2025-523201-14-00
3. fázisTaking people
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Where
Brentwood, Clifton Park, Dallas, Denver, Houston, Iowa City, New York, Orlando
Életkor
18 év to 100 év
People
220 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06858319
2. fázisTaking people
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Where
Atlanta, Dakota Dunes, Denver, Hinsdale, Houston, Los Angeles, San Antonio, Tamarac
Életkor
18 év to 75 év
People
96 worldwide
Run by
Walden Biosciences
See details and how to joinNCT06466135
3. fázisTaking people
Study of Ravulizumab in Pediatric Participants With Primary IgAN
Where
Aurora, Palo Alto
Életkor
2 év to 18 év
People
36 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07024563 · EU 2024-520167-13-00
2. fázisTaking people
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
Where
Birmingham, Chubbuck, Cleveland, Columbus, Houston, Las Vegas, Lawrenceville, Los Angeles, Orlando
Életkor
18 év to 99 év
People
20 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06797518
2. fázisTaking people
Atacicept in Multiple Glomerular Diseases
Where
Brisbane
Életkor
2 év and over
People
250
Run by
Vera Therapeutics, Inc.
See details and how to joinNCT06983028
1. fázisTaking people
Study of BHV-1400 in IgA Nephropathy
Where
Chesterfield, Dakota Dunes, Farmington, Hinsdale, Houston, Indianapolis, Lawrenceville, Miami Lakes, Orlando, Pembroke Pines, Salt Lake City, Shelby
Életkor
18 év to 65 év
People
20 worldwide
Run by
Biohaven Therapeutics Ltd.
See details and how to joinNCT07054684
2. fázisCsak meghívásos
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept
Where
Brisbane
Életkor
18 év to 99 év
People
750
Run by
Vera Therapeutics, Inc.
See details and how to joinNCT06674577
2. fázisTaking people
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Where
Ann Arbor, Boston, Chapel Hill, Charlotte, Columbus, Durham, Hackensack, Houston, Iowa City, Kansas City, Los Angeles, Miami, Minneapolis, Neptune City, New Hyde Park, New York, Oklahoma City, Philadelphia, Seattle, Wilmington
Életkor
1 év to 17 év
People
67 worldwide
Run by
Travere Therapeutics, Inc.
See details and how to joinNCT05003986 · EU 2023-505497-14-00
2/3. fázisCsak meghívásos
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
Where
Atlanta, Birmingham, Boston, Columbus, Dakota Dunes, Denver, Great Neck, Houston, Lauderdale Lakes, Lawrenceville, Los Angeles, Milwaukee, Palo Alto, Shelby, Worcester
Életkor
18 év and over
People
600 worldwide
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT05248659
No phaseTaking people
A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US
Where
Boston
Életkor
18 év and over
People
300
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06952426